TP53 and cancer: Endogenous CCDC106 and p53 can be colocalized in nuclei and interact with each other in vivo, promoting the degradation of the p53 protein and inhibiting its transactivation activity1, suggesting that CCDC106 is a negative regulator of p53 to promote cell proliferation in cancers.